Clinical Trials Logo

Metastatic Biliary Tract Cancer clinical trials

View clinical trials related to Metastatic Biliary Tract Cancer.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05742750 Not yet recruiting - Clinical trials for Metastatic Biliary Tract Cancer

A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer

Start date: March 1, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The objective of this study is to investigate the safety and tolerability of camrelizumab combined with apatinib and chemotherapies (gemcitabine and cisplatin) in patients with advanced biliary tract cancer (BTC).